Falsified Medicines Directive in a Secondary Care Environment-Impact on Supply Chain.
delegated regulation
falsified medicines directive
hospital
supply chain
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
10 03 2022
10 03 2022
Historique:
received:
19
11
2021
revised:
28
02
2022
accepted:
04
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
20
4
2022
Statut:
epublish
Résumé
The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) impact the pharmaceutical supply chain. Ahead of the deadline for implementation, in February 2019, every entity of the supply chain had to adapt its operations to the regulatory requirements to be compliant with the directive. This paper analyzes the supply chain of a hospital pharmacy and the impact of the FMD implementation. Furthermore, a cost analysis was performed demonstrating that the FMD increases expenditure in the secondary care environment dispensing operations. Governments should be aware that this regulation will certainly impact public healthcare institutions in the long term.
Identifiants
pubmed: 35328963
pii: ijerph19063276
doi: 10.3390/ijerph19063276
pmc: PMC8953181
pii:
doi:
Substances chimiques
Counterfeit Drugs
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
BMJ Open. 2020 Jan 9;10(1):e033405
pubmed: 31924640
Eur J Hosp Pharm. 2016 Mar;23(2):118-120
pubmed: 27019711
Pharmacy (Basel). 2020 Mar 09;8(1):
pubmed: 32182834
Pharmacy (Basel). 2016 Mar 28;4(2):
pubmed: 28970389
J Generic Med. 2014 Sep;11(3-4):169-172
pubmed: 26435721
Pharmacy (Basel). 2017 Nov 09;5(4):
pubmed: 29120385
Pharmacoeconomics. 2018 Dec;36(12):1395-1405
pubmed: 30062518
Eur J Hosp Pharm. 2018 Jan;25(1):10-15
pubmed: 29445453